A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia.

[1]  Hanna Göransson,et al.  Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia , 2011, Haematologica.

[2]  A. Berrebi,et al.  Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial , 2010, The Lancet.

[3]  B. Lakshmi,et al.  Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). , 2009, Blood.

[4]  M. Dyer,et al.  A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL , 2008, Leukemia.

[5]  R. Siebert,et al.  Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  T Hamblin,et al.  Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial , 2007, The Lancet.

[7]  Jens Timmer,et al.  Using High-density Snp Arrays Genome-wide Analysis of Dna Copy Number Changes and Loh in Cll , 2022 .

[8]  A Benner,et al.  Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[9]  M. James,et al.  Erratum: Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders (Proceedings of the National Academy of Sciences of the United States of America (October 15, 1996) 93:21 (11837-11841)) , 1996 .

[10]  M. James,et al.  Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Gahrton,et al.  Chromosome abnormalities and RB1 gene deletions in chronic lymphocytic leukemia. , 1993, Blood.

[12]  G. Gahrton,et al.  Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. , 1990, Cancer genetics and cytogenetics.

[13]  A. Isaksson,et al.  Array-based genomic screening at diagnosis and follow-up in chronic lymphocytic leukemia , 2011 .

[14]  M. Lowery-Nordberg,et al.  Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia , 2009, Leukemia.

[15]  L. Shaffer,et al.  Comprar ISCN 2009 - An International System for Human Cytogenetic Nomenclature | Marilyn L. Slovak | 9783805589857 | Karger AG , 2009 .

[16]  P. Oefner,et al.  Denaturing high-performance liquid chromatography. , 2003, Methods in molecular biology.

[17]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .